Sola Security Launches Lumina, an Autonomous Security Deep Research Platform for Actionable Risk Intelligence Modern Wealth Creation Courses Now Available Online from For Best University
The online community will teach students from all walks of life Milan, Italy–(Newsfile Corp. –…
BELGRAVIA HARTFORD Provides Year End Update on Zonetail Litigation
Toronto, Ontario–(Newsfile Corp. – December 20, 2022) – BELGRAVIA HARTFORD CAPITAL INC. (CSE: BLGV) (“Belgravia…
Sphere 3D Corp. Increases Production Capacity by Approximately 267%
More than 2,665 new miners started hashing at the Wolf Hollow site Production capacity jumps…
Snow Lake Lithium Corrects the Record and Confirms Postponed Meeting Date for January 17, 2023
MANITOBA, CANADA, Dec 21, 2022 – (ACN Newswire) – Snow Lake Resources Ltd., d/b/a Snow…
Wedge and Fiserv Enable Financial Institution Access To Innovative Programmable Payments Capabilities
Financial institutions of all sizes can offer consumers a debit card that optimizes cash flow…
Stream Data Centers Expands Strategic Leadership with Newly Appointed VP of Finance Callan Space
New Leadership Brings a Wealth of Executive Experience Guiding Hyperscale Growth and Financial Success Dallas,…
Magenta Therapeutics Provides Update for MGTA-117 Phase 1/2 Dose Escalation Clinical Trial
– Cohort 4 Dosing Stopped per Clinical Trial Protocol due to Dose-Limiting Toxicities – –…
Updated Invectys and CTMC announce FDA clearance of IND application for anti-HLA-G CAR-T cell therapy
FDA granted IND clearance for IVS-3001, Invectys’s lead engineered anti-HLA–G CAR-T cell therapy, for the…
Journey Medical Corporation Announces Positive Comparative Pharmacokinetic (PK) Data for DFD-29
Phase 3, registrational studies remain on track for first half of 2023 topline data readout…
Achilles Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
LONDON, Dec. 20, 2022 (GLOBE NEWSWIRE) — Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical…
POINT Biopharma Announces Closing of Agreements with Lantheus Holdings
INDIANAPOLIS, Dec. 20, 2022 (GLOBE NEWSWIRE) — POINT Biopharma Global Inc. (“POINT”) (NASDAQ: PNT), a…
IGC Announces Updated Life Sciences Presentation
POTOMAC, Md., Dec. 20, 2022 (GLOBE NEWSWIRE) — India Globalization Capital, Inc. (NYSE American: IGC)…
Athenex Announces Quantum Leap Healthcare Collaborative Reports Positive Trial Result of I-SPY2 Trial for Oral Paclitaxel in Combination with PD-1 and Carboplatin in Neoadjuvant Breast Cancer
Oral Paclitaxel combination regimen has graduated in this Phase 2 trial in the triple negative…
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
FOSTER CITY, Calif., Dec. 20, 2022 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the…
Quris Earns Additional Seed Investment Led by SoftBank Vision Fund 2
AI Innovator Expands Seed Funding to $37 Million With Latest $9 Million Investment, Strengthening Momentum…
Eyenovia Announces Participation at the 2023 International Consumer Electronics Show
Booth to feature “smart” remote patient monitoring capabilities being developed for future versions of the…
MediWound Strengthens European Presence of NexoBrid®
NexoBrid gained marketing approval in Switzerland; launch expected first quarter 2023 Launch in France expected…
Immix Biopharma Announces 16th Patient Dosing in Ongoing Phase 1b/2a IMX-110 Monotherapy Clinical Trial
16th patient dosed with IMX-110 to date This is the second patient dosed with IMX-110…
Erasca Announces First Patient Dosed in HERKULES-1 Phase 1b Trial Evaluating ERAS-007 and ERAS-601 MAPKlamp Combination in RAS/MAPK Pathway-Altered Solid Tumors
Promising preliminary monotherapy data for ERK1/2 inhibitor ERAS-007 and SHP2 inhibitor ERAS-601 in advanced solid…
Sunshine Biopharma’s Annual Letter to Shareholders
MONTREAL, Dec. 20, 2022 (GLOBE NEWSWIRE) — Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company…